CDNA - CIK 0001217234
The table below shows CareDx, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $4.33M | -$26.58M | -$15.31M | $671.00K | -$21.47M | -$33.63M |
| Capital expenditure | $3.82M | $1.63M | - | - | - | $1.25M |
| Investing cash flow | $11.06M | $1.32M | $27.66M | -$14.77M | -$156.03M | $19.08M |
| Dividends paid | - | - | - | - | - |
CareDx, Inc. reported operating cash flow of $42.03M for fiscal year 2025. That is up 10.5% from $38.05M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$16.52M (FY 2016) to $42.03M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | $0.00 | $522.00K | $690.00K | $0.00 | - |
| Financing cash flow | -$2.91M | -$643.00K | -$1.27M | -$1.14M | $865.00K | $189.23M |